These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9479035)
1. Cross-sensitization between footshock stress and apomorphine on self-injurious behavior and neostriatal catecholamines in a rat model of Lesch-Nyhan syndrome. Stodgell CJ; Loupe PS; Schroeder SR; Tessel RE Brain Res; 1998 Feb; 783(1):10-8. PubMed ID: 9479035 [TBL] [Abstract][Full Text] [Related]
2. Fixed-ratio discrimination training as replacement therapy in Parkinson's disease: studies in a 6-hydroxydopamine-treated rat model. Van Keuren KR; Stodgell CJ; Schroeder SR; Tessel RE Brain Res; 1998 Jan; 780(1):56-66. PubMed ID: 9473587 [TBL] [Abstract][Full Text] [Related]
3. A dopamine deficiency model of Lesch-Nyhan disease--the neonatal-6-OHDA-lesioned rat. Breese GR; Criswell HE; Duncan GE; Mueller RA Brain Res Bull; 1990 Sep; 25(3):477-84. PubMed ID: 2127238 [TBL] [Abstract][Full Text] [Related]
4. Relationship of dopamine to serotonin in the neonatal 6-OHDA rat model of Lesch-Nyhan syndrome. Allen SM; Davis WM Behav Pharmacol; 1999 Sep; 10(5):467-74. PubMed ID: 10780253 [TBL] [Abstract][Full Text] [Related]
5. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306 [TBL] [Abstract][Full Text] [Related]
6. Fixed ratio discrimination training increases in vivo striatal dopamine in neonatal 6-OHDA-lesioned rats. Loupe PS; Zhou X; Davies MI; Schroeder SR; Tessel RE; Lunte SM Pharmacol Biochem Behav; 2002 Dec; 74(1):61-71. PubMed ID: 12376153 [TBL] [Abstract][Full Text] [Related]
7. Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats. Pollack AE; Strauss JB Brain Res; 1999 May; 827(1-2):160-8. PubMed ID: 10320705 [TBL] [Abstract][Full Text] [Related]
8. p-Chloroamphetamine-Enhanced Neostriatal Dopamine Exocytosis in Rats Neonatally Co-lesioned with 6-OHDA and 5,7-DHT: Relevance to Parkinson's Disease. Kostrzewa JP; Kostrzewa RM Neurotox Res; 2020 Mar; 37(3):543-552. PubMed ID: 31939043 [TBL] [Abstract][Full Text] [Related]
9. Abnormal involuntary movement (AIM) expression following D2 dopamine agonist challenge is determined by the nature of prior dopamine receptor stimulation (priming) in 6-hydroxydopamine lesioned rats. Drake JD; Kibuuka LN; Dimitrov KD; Pollack AE Pharmacol Biochem Behav; 2013 Apr; 105():26-33. PubMed ID: 23369985 [TBL] [Abstract][Full Text] [Related]
10. EEG modifications in the cortex and striatum after dopaminergic priming in the 6-hydroxydopamine rat model of Parkinson's disease. Vorobyov VV; Schibaev NV; Morelli M; Carta AR Brain Res; 2003 May; 972(1-2):177-85. PubMed ID: 12711091 [TBL] [Abstract][Full Text] [Related]
11. Action sites of rotation and unit firing induced by l-stepholidine and DA agonists in basal ganglia of 6-OHDA-lesioned rats. Zhang XX; Liu J; Fu Y; Hu GY; Jin GZ Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):979-86. PubMed ID: 11270978 [TBL] [Abstract][Full Text] [Related]
12. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development. Neal-Beliveau BS; Joyce JN Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220 [TBL] [Abstract][Full Text] [Related]
13. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior. Sivam SP Brain Res; 1989 Oct; 500(1-2):119-30. PubMed ID: 2481560 [TBL] [Abstract][Full Text] [Related]
14. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons. Frau L; Morelli M; Simola N Exp Neurol; 2013 Sep; 247():663-72. PubMed ID: 23499830 [TBL] [Abstract][Full Text] [Related]
15. Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats. Inaji M; Okauchi T; Ando K; Maeda J; Nagai Y; Yoshizaki T; Okano H; Nariai T; Ohno K; Obayashi S; Higuchi M; Suhara T Brain Res; 2005 Dec; 1064(1-2):136-45. PubMed ID: 16298352 [TBL] [Abstract][Full Text] [Related]
16. Multiple single-unit recordings in the striatum of freely moving animals: effects of apomorphine and D-amphetamine in normal and unilateral 6-hydroxydopamine-lesioned rats. Kish LJ; Palmer MR; Gerhardt GA Brain Res; 1999 Jun; 833(1):58-70. PubMed ID: 10375677 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of risperidone in the neonatal 6-hydroxydopamine model of Lesch-Nyhan syndrome. Allen SM; Freeman JN; Davis WM Pharmacol Biochem Behav; 1998 Feb; 59(2):327-30. PubMed ID: 9476977 [TBL] [Abstract][Full Text] [Related]
18. Dopamine agonist induced self-mutilative biting behavior in monkeys with unilateral ventromedial tegmental lesions of the brainstem: possible pharmacological model for Lesch-Nyhan syndrome. Goldstein M; Kuga S; Kusano N; Meller E; Dancis J; Schwarcz R Brain Res; 1986 Mar; 367(1-2):114-20. PubMed ID: 2938664 [TBL] [Abstract][Full Text] [Related]
19. The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat--an autoradiographic study. Gnanalingham KK; Robertson RG Brain Res; 1994 Mar; 640(1-2):185-94. PubMed ID: 8004447 [TBL] [Abstract][Full Text] [Related]
20. Neonatal-6-hydroxydopamine treatment: model of susceptibility for self-mutilation in the Lesch-Nyhan syndrome. Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Mueller RA Pharmacol Biochem Behav; 1984 Sep; 21(3):459-61. PubMed ID: 6436840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]